MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Move amid evidence of widespread reporting gaps
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Subscribe To Our Newsletter & Stay Updated